These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20598929)

  • 1. Theoretical prediction of a peptide binding to major histocompatibility complex II.
    Aldulaijan S; Platts JA
    J Mol Graph Model; 2010 Sep; 29(2):240-5. PubMed ID: 20598929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and evaluation of MHC class II binding peptides.
    de Haan EC; Wauben MH; Grosfeld-Stulemeyer MC; Moret EE
    Biologicals; 2001; 29(3-4):289-92. PubMed ID: 11851330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-empirical molecular orbital methods including dispersion corrections for the accurate prediction of the full range of intermolecular interactions in biomolecules.
    McNamara JP; Hillier IH
    Phys Chem Chem Phys; 2007 May; 9(19):2362-70. PubMed ID: 17492099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian regression approach to the prediction of MHC-II binding affinity.
    Zhang W; Liu J; Niu YQ; Wang L; Hu X
    Comput Methods Programs Biomed; 2008 Oct; 92(1):1-7. PubMed ID: 18562039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R; Springer S; Zacharias M
    Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide binding to major histocompatibility complex: prediction and characterization using an evolutionary algorithmic approach.
    Rajapakse M; Feng L
    IEEE Eng Med Biol Mag; 2009; 28(4):73-7. PubMed ID: 19622428
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of peptide binding to major histocompatibility complex class II molecules through use of boosted fuzzy classifier with SWEEP operator method.
    Takahashi H; Honda H
    J Biosci Bioeng; 2006 Feb; 101(2):137-41. PubMed ID: 16569609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of Ab initio predictions of peptide binding to MHC class II molecules.
    Zhang H; Wang P; Papangelopoulos N; Xu Y; Sette A; Bourne PE; Lund O; Ponomarenko J; Nielsen M; Peters B
    PLoS One; 2010 Feb; 5(2):e9272. PubMed ID: 20174654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BiodMHC: an online server for the prediction of MHC class II-peptide binding affinity.
    Wang L; Pan D; Hu X; Xiao J; Gao Y; Zhang H; Zhang Y; Liu J; Zhu S
    J Genet Genomics; 2009 May; 36(5):289-96. PubMed ID: 19447377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide binding to MHC class I and II proteins: new avenues from new methods.
    Yaneva R; Schneeweiss C; Zacharias M; Springer S
    Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic isomers of a class II MHC-peptide complex.
    Schmitt L; Boniface JJ; Davis MM; McConnell HM
    Biochemistry; 1998 Dec; 37(50):17371-80. PubMed ID: 9860852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural prediction of peptides bound to MHC class I.
    Fagerberg T; Cerottini JC; Michielin O
    J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of MHC class II binders using the ant colony search strategy.
    Karpenko O; Shi J; Dai Y
    Artif Intell Med; 2005; 35(1-2):147-56. PubMed ID: 16061368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
    Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
    Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.